$41

Liporase Hyaluronidase 1500 IU – Precision Solution for HA Filler Correction

Product Description

Liporase Hyaluronidase 1500 IU is a fast-acting injectable enzyme used to dissolve hyaluronic acid-based dermal fillers safely and effectively. Popular in aesthetic medicine, it allows practitioners to correct overfilled, misplaced, or uneven filler results. Its rapid onset and high purity make it a trusted choice for both planned corrections and urgent interventions.

Formulation

• Active Ingredient: Hyaluronidase 1500 IU – an enzyme that hydrolyzes hyaluronic acid, breaking it down into smaller sugar molecules for natural absorption by the body. It selectively degrades synthetic HA without impacting native tissue.

• Excipient: Lactose monohydrate 13.3 mg – acts as a stabilizer in the lyophilized formulation

Benefits

• Dissolves HA fillers quickly and safely

• Helps correct aesthetic asymmetry or overcorrection

• Aids in managing vascular complications due to filler placement

• Assists in preparing areas for re-treatment

• Minimal side effects with visible results in 24–48 hours

Scope of Application

• Lips, cheeks, under-eye, and nasolabial fold corrections

• Emergency filler reversal due to vascular compromise

• Pre-treatment filler clearance

• Fat-dissolving enhancement when used adjunctively

Indication

• Filler correction for hyaluronic acid-based injectables

• Management of filler-related complications

• Enhanced subcutaneous drug dispersion

Duration of Effect

• Starts working within minutes of injection

• Full breakdown of HA typically complete within 24–48 hours

• Follow-up evaluation recommended after 1 week

Packaging and Specifications

• Contents: 10 vials per box

• Dose per Vial: 1500 IU (lyophilized powder)

• Dilution: Commonly mixed with 3–5 mL of saline before injection

• Needles/Syringes: Not included

• Storage: Store in a cool, dry place (2–25°C) away from direct sunlight

• Shelf Life: Refer to packaging for expiration date

• Form: Sterile lyophilized powder to be reconstituted with saline

• Administration: Subcutaneous, intradermal, or intramuscular injection

• Manufacturer: Daehan New Pharm Co., Ltd., South Korea